Sports Medicine Devices – Market Insights – Asia Pacific

Favorable demographics, investment in enabling technologies, uptake of premium-priced products, and increased availability and quality of surgeon training will help the market grow at a rapid pace through the forecast period. However, cost controls due to budgetary constraints, regulatory challenges, and the prevalence of alternative treatments will limit ASPs and revenue expansion over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for sports medicine devices in Asia Pacific from 2019 to 2032.

The sports medicine device market is growing due to the adoption of premium-priced technology.

What product innovations are competitors pursuing in order to capitalize on the growing sports medicine device market segments?

How much penetration have current-generation implantable devices gained across the sports medicine device market.

How does the adoption of these premium-priced devices vary by country?

Large global orthopedic device manufacturers continue to hold the majority of revenues.

Who are the leading competitors, and how have they performed in each of the device segments?

What strategies have leading device manufacturers used to grow in the market?

What strategies can smaller competitors use to gain market share?

Which product segments should competitors focus on for growth opportunities?

Price competition and the usage of reprocessed devices will limit revenue growth potential, especially in light of increased cost-consciousness among healthcare facilities.

How will ASP trends vary by country?

What are the effects of downward pricing pressure on ASPs, and which product segments will be most impacted?

Which segments will experience the most price competition?

How does the usage of reprocessed sports medicine devices vary by country?

In comparison to Australia and South Korea, the sports medicine device markets in India and China are relatively underpenetrated.

What are the factors responsible for low penetration in India and China?

What strategies will competitors use in these markets to gain revenues?

Table of contents